Standard Biotools (LAB) Non-Current Assets (2010 - 2026)
Standard Biotools (LAB) posted quarterly Non-Current Assets of $117.7 million for Q1 2026, down 50.05% year-over-year from $235.6 million in Q1 2025, and up 3.68% quarter-over-quarter from $113.5 million in Q4 2025.
Standard Biotools (LAB) Non-Current Assets (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Non-Current Assets for 17 consecutive years, with $117.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 50.05% year-over-year to $117.7 million; the TTM figure through Mar 2026 stood at $349.3 million (down 62.39% YoY), while the FY2025 annual figure was $113.5 million, down 52.0% from the prior year.
- Non-Current Assets grew to $117.7 million in Q1 2026 per LAB's latest filing, from $113.5 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $236.5 million in Q4 2024 and bottomed at $50.9 million in Q2 2025.
- Historically, Non-Current Assets has averaged $173.4 million across 5 years, with a median of $181.5 million in 2022.
- Annual changes were most pronounced in 2024 — Non-Current Assets jumped 43.44% — and 2025, when it tumbled 77.73%.
- Standard Biotools' Non-Current Assets stood at $181.5 million in 2022, then declined by 9.17% to $164.9 million in 2023, then soared by 43.44% to $236.5 million in 2024, then plunged by 52.0% to $113.5 million in 2025, then advanced by 3.68% to $117.7 million in 2026.
- Business Quant data shows LAB's Non-Current Assets at $117.7 million in Q1 2026, $113.5 million in Q4 2025, and $67.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Standard Biotools | 250.59 Mn | -226.13 Mn | 10.54 Mn | 110.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 110.35 Mn |
| Mar 31, 2026 | 117.66 Mn |
| Dec 31, 2025 | 113.49 Mn |
| Sep 30, 2025 | 67.20 Mn |
| Jun 30, 2025 | 50.93 Mn |
| Mar 31, 2025 | 235.58 Mn |
| Dec 31, 2024 | 236.46 Mn |
| Sep 30, 2024 | 227.93 Mn |
| Jun 30, 2024 | 228.70 Mn |
| Mar 31, 2024 | 230.10 Mn |
| Dec 31, 2023 | 164.85 Mn |
| Sep 30, 2023 | 168.54 Mn |
| Jun 30, 2023 | 172.76 Mn |
| Mar 31, 2023 | 176.73 Mn |
| Dec 31, 2022 | 181.50 Mn |
| Sep 30, 2022 | 185.90 Mn |
| Jun 30, 2022 | 190.25 Mn |
| Mar 31, 2022 | 198.74 Mn |
| Dec 31, 2021 | 203.15 Mn |
| Sep 30, 2021 | 208.72 Mn |